Sirt1 interaction with active Smad2 modulates transforming growth factor-β regulated transcription
Open Access
- 29 November 2017
- journal article
- research article
- Published by Springer Nature in Cell Communication and Signaling
- Vol. 15 (1) , 50
Abstract
The simplicity of Transforming Growth Factor ß (TGFβ) signaling pathway, linear and non-amplified, hardly sustains its variety of responses. This is often justified by the complex regulation showed by Smad proteins, TGFβ signaling intracellular transducers, object of post-translational modifications that modulate TGFβ-dependent transcription. Protein acetylation is emerging as a compelling mechanism affecting the activities of significant transcription factors, including p53, FOXO or NF-kB. Smad proteins might be controlled by this mechanism, implying that accessory factors capable of altering Smads-transcriptional complexes acetylation status and hence regulate TGFβ responses remain to be identified. Understanding this interaction may help in the assessment of TGFβ signaling outcomes, extending from healthy physiology to pathological conditions and cancer. A two-hybrid chimera interacting system allowed to identify Sirt1, a NAD+ dependent type III histone deacetylase, as a novel Smad2 interactor. Several well stablished cellular models were applied to characterize this interaction by means of co-immunoprecipitation of tagged proteins and immuno-fluorescence staining. The occurrence of the interaction at Smad2 driven transcriptomic complexes was studied by means of DNA-pull-down and chromatin immunoprecipitation (ChIP), while its effects were assessed by protein over-expression and siRNA applied into a TGFβ-dependent reporter gene assay. The interaction was confirmed and observed to be enhanced upon Smad2 acetylation, a known feature of active and nuclear Smad2. However, Sirt1 did not play a major role in Smad2 deacetylation. Anti-Sirt1 ChIP showed increased recovery of promoter regions corresponding to Smad2-driven genes after TGFβ-stimulation, while its occurrence at Smad2-dependent transcriptomic complexes on DNA was found to effectively modulate gene expression. Sirt1 presence on Smad2-driven TGFβ-dependent regulatory elements was detected and found to increase after TGFβ treatment. Moreover, Sirt1 overexpression resulted in a decrease of the activity of a Smad2-driven TGFβ-dependent reporter gene, while Sirt1 interference increased its activity. This would confirm the relevance of the discovered Sirt1-Smad2 interaction for the regulation of TGFβ-dependent gene transcription.Keywords
Funding Information
- Spanish Ministry of Education and Science (SAF2006-09482, SAF2003-06029)
- Instituto de Salud Carlos III (PI13/00794)
This publication has 75 references indexed in Scilit:
- Genome-wide mechanisms of Smad bindingOncogene, 2012
- SIRT1 Contains N- and C-terminal Regions That Potentiate Deacetylase ActivityJournal of Biological Chemistry, 2012
- The Type III Histone Deacetylase Sirt1 Protein Suppresses p300-mediated Histone H3 Lysine 56 Acetylation at Bclaf1 Promoter to Inhibit T Cell ActivationJournal of Biological Chemistry, 2011
- To (TGF)β or not to (TGF)β: Fine-tuning of Smad signaling via post-translational modificationsCellular Signalling, 2008
- Identification of novel Smad2 and Smad3 associated proteins in response to TGF‐β1Journal of Cellular Biochemistry, 2008
- Sirtuins in mammals: insights into their biological functionBiochemical Journal, 2007
- Smads orchestrate specific histone modifications and chromatin remodeling to activate transcriptionThe EMBO Journal, 2006
- New insights into TGF-β–Smad signallingTrends in Biochemical Sciences, 2004
- Transcriptional coregulator SNW/SKIP: the concealed tie of dissimilar pathwaysCellular and Molecular Life Sciences, 2004
- Attenuation of the TGF-β-Smad signaling pathway in pancreatic tumor cells confers resistance to TGF-β-induced growth arrestOncogene, 2003